Felix Glocker’s Post

🏆 Hemodynamix wins the Hessen Ideen Competition 2026! Yesterday in Frankfurt, our team was awarded 1st place at the Hessen Ideen Wettbewerb, competing against eleven outstanding finalist teams from universities across Hesse. We are proud, grateful, and more motivated than ever. Hemodynamix unlocks information that is already there. Cardiac pressure curves are recorded during many routine procedures, but most of what they reveal about heart function goes unused. Our software analyzes this existing data with advanced algorithms, with no extra catheters and no extra workload for clinical teams. Our prototype is already being used in clinical studies to systematically evaluate ventricular pressure curves. This recognition would not have been possible without many people, and we want to say thank you: ➡️ Hessen Ideen and the Hessian Ministry of Science and Research, Arts and Culture (HMWK) for creating a platform that brings research-based startup ideas into the spotlight ➡️ The ECM team for encouraging us to compete in the first place ➡️ The jury for their time, sharp questions, and trust in our idea ➡️ Justus-Liebig-Universität Gießen, the Tello Lab, the Cardio-Pulmonary Institute (CPI), and the Institute for Lung Health (ILH) for their continuous support ➡️ Our fellow finalists: it was an honor to pitch alongside you What comes next With this milestone behind us, our focus is now clear: commercialization. We are moving from a validated research prototype toward a product that can be used in everyday clinical practice. We know this path is not easy. MedTech ranks among the most demanding fields for startups: certification under the EU Medical Device Regulation (MDR) and, for the US market, FDA clearance, robust clinical validation, quality management systems, long hospital sales cycles, and questions of reimbursement all require time, expertise, and capital. Many promising innovations never make it past these hurdles. We are preparing for exactly these challenges: by building on our strong clinical and scientific foundation, planning the regulatory pathway early, and growing a team and network that can carry Hemodynamix from the lab into the clinic. Let's talk 🤝 We are looking for investors and partners who share our belief that better use of existing clinical data can transform cardiovascular care, and who have the patience and experience to back a MedTech journey. If that sounds like you, or you know someone who should hear about Hemodynamix, please reach out. Univ. Prof Dr. med. Khodr Tello - Dr. med. Nils Kremer - Carolin Oetterer Tristan Herbold - Werner Seeger - Hessen Ideen - Hessisches Ministerium für Wissenschaft und Forschung, Kunst und Kultur - ECM - Gründungszentrum der JLU - Cardio-Pulmonary Institute - Institute for Lung Health (ILH) - Justus-Liebig-Universität Giessen #HessenIdeen #Hemodynamix #MedTech #DigitalHealth #Startup #Investment #Commercialization #MDR #FDA #Innovation #JLUGiessen #Hessen